SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-020388
Filing Date
2012-04-05
Accepted
2012-04-05 16:28:57
Documents
6
Period of Report
2012-04-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v308645_8k.htm 8-K 24515
2 EXHIBIT 10.1 v308645_ex10-1.htm EX-10.1 72067
3 EXHIBIT 10.2 v308645_ex10-2.htm EX-10.2 73435
4 EXHIBIT 10.3 v308645_ex10-3.htm EX-10.3 76451
5 EXHIBIT 10.4 v308645_ex10-4.htm EX-10.4 75414
6 EXHIBIT 10.5 v308645_ex10-5.htm EX-10.5 76357
  Complete submission text file 0001144204-12-020388.txt   399514
Mailing Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154
Business Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154 5184640279
ALBANY MOLECULAR RESEARCH INC (Filer) CIK: 0001065087 (see all company filings)

IRS No.: 141742717 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25323 | Film No.: 12745964
SIC: 8731 Services-Commercial Physical & Biological Research